{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:02:53Z","timestamp":1789016573563,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Jiangsu Province Creation Team and Leading Talents Project"},{"name":"Intestine Initiative Foundation"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600417"],"award-info":[{"award-number":["81600417"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670495"],"award-info":[{"award-number":["81670495"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Top-notch Talent Research Projects","award":["LGY2017080"],"award-info":[{"award-number":["LGY2017080"]}]},{"name":"Project of National Health and Family Planning Commission","award":["201502026"],"award-info":[{"award-number":["201502026"]}]},{"name":"National Clinical Research Center for Digestive Diseases, Xi\u2019an, China","award":["2015BAI13B07"],"award-info":[{"award-number":["2015BAI13B07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1007\/s40264-019-00809-2","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T15:41:16Z","timestamp":1554910876000},"page":"869-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis"],"prefix":"10.1007","volume":"42","author":[{"given":"Xiao","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bota","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-1144","authenticated-orcid":false,"given":"Faming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"issue":"6","key":"809_CR1","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146(6):1489\u201399.","journal-title":"Gastroenterology."},{"issue":"6","key":"809_CR2","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/j.gastro.2014.01.050","volume":"146","author":"F Shanahan","year":"2014","unstructured":"Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD: challenges and controversies. Gastroenterology. 2014;146(6):1554\u201363.","journal-title":"Gastroenterology."},{"issue":"11","key":"809_CR3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/ajg.2012.251","volume":"107","author":"F Zhang","year":"2012","unstructured":"Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107(11):1755 (author reply 1756).","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"809_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/MOG.0000000000000027","volume":"30","author":"TJ Borody","year":"2014","unstructured":"Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol. 2014;30(1):97\u2013105.","journal-title":"Curr Opin Gastroenterol."},{"issue":"8630","key":"809_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(89)91183-5","volume":"1","author":"JD Bennet","year":"1989","unstructured":"Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;1(8630):164.","journal-title":"Lancet."},{"issue":"6","key":"809_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/MPG.0b013e318292fa0d","volume":"56","author":"S Kunde","year":"2013","unstructured":"Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H Jr, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr. 2013;56(6):597\u2013601.","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"1","key":"809_CR7","doi-asserted-by":"publisher","first-page":"102-9.e6","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149(1):102-9.e6.","journal-title":"Gastroenterology."},{"issue":"1","key":"809_CR8","doi-asserted-by":"publisher","first-page":"110-8.e4","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen NG, Fuentes S, van der Spek MJ, Tijssen JG, Hartman JH, Duflou A, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110-8.e4.","journal-title":"Gastroenterology."},{"issue":"10075","key":"809_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218\u201328.","journal-title":"Lancet."},{"issue":"4","key":"809_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","volume":"10","author":"S Vermeire","year":"2016","unstructured":"Vermeire S, Joossens M, Verbeke K, Wang J, Machiels K, Sabino J, et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis. 2016;10(4):387\u201394.","journal-title":"J Crohns Colitis."},{"issue":"4","key":"809_CR11","doi-asserted-by":"publisher","first-page":"799-811.e7","DOI":"10.1053\/j.gastro.2016.11.010","volume":"152","author":"SJ Ott","year":"2017","unstructured":"Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology. 2017;152(4):799-811.e7.","journal-title":"Gastroenterology."},{"issue":"1","key":"809_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/jgh.12727","volume":"30","author":"B Cui","year":"2015","unstructured":"Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn\u2019s disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30(1):51\u20138.","journal-title":"J Gastroenterol Hepatol."},{"key":"809_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-015-0646-2","volume":"13","author":"B Cui","year":"2015","unstructured":"Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015;13:298.","journal-title":"J Transl Med."},{"issue":"41","key":"809_CR14","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3748\/wjg.v19.i41.7213","volume":"19","author":"FM Zhang","year":"2013","unstructured":"Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn\u2019s disease. World J Gastroenterol. 2013;19(41):7213\u20136.","journal-title":"World J Gastroenterol."},{"issue":"5","key":"809_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s13238-018-0541-8","volume":"9","author":"F Zhang","year":"2018","unstructured":"Zhang F, Cui B, He X, Nie Y, Wu K, Fan D, et al. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9(5):462\u201373.","journal-title":"Protein Cell."},{"issue":"7728","key":"809_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart CJ, Ajami NJ, O\u2019Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583\u20138.","journal-title":"Nature."},{"issue":"7402","key":"809_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486(7402):222\u20137.","journal-title":"Nature."},{"issue":"1","key":"809_CR18","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1038\/s41598-017-04984-z","volume":"7","author":"Z He","year":"2017","unstructured":"He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn\u2019s disease complicated with inflammatory mass. Sci Rep. 2017;7(1):4753.","journal-title":"Sci Rep."},{"issue":"6","key":"809_CR19","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.1055\/s-0042-105205","volume":"4","author":"Z Peng","year":"2016","unstructured":"Peng Z, Xiang J, He Z, Zhang T, Xu L, Cui B, et al. Colonic transendoscopic enteral tubing: a novel way of transplanting fecal microbiota. Endosc Int Open. 2016;4(6):E610\u20133.","journal-title":"Endosc Int Open."},{"issue":"7","key":"809_CR20","doi-asserted-by":"publisher","first-page":"1775-83.e2","DOI":"10.1053\/j.gastro.2015.08.044","volume":"149","author":"N Yoshimura","year":"2015","unstructured":"Yoshimura N, Watanabe M, Motoya S, Tominaga K, Matsuoka K, Iwakiri R, et al. Safety and efficacy of AJM300, an oral antagonist of alpha4 integrin, in induction therapy for patients with active ulcerative colitis. Gastroenterology. 2015;149(7):1775-83.e2.","journal-title":"Gastroenterology."},{"issue":"10","key":"809_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/apt.13594","volume":"43","author":"DC Baumgart","year":"2016","unstructured":"Baumgart DC, Bokemeyer B, Drabik A, Stallmach A, Schreiber S, Vedolizumab Germany C. Vedolizumab induction therapy for inflammatory bowel disease in clinical practice: a nationwide consecutive German cohort study. Aliment Pharmacol Ther. 2016;43(10):1090\u2013102.","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"809_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cgh.2013.09.060","volume":"12","author":"CR Kelly","year":"2014","unstructured":"Kelly CR, Kunde SS, Khoruts A. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clin Gastroenterol. 2014;12(2):283\u20138.","journal-title":"Clin Gastroenterol."},{"issue":"4","key":"809_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/19490976.2016.1151608","volume":"7","author":"B Cui","year":"2016","unstructured":"Cui B, Li P, Xu L, Peng Z, Xiang J, He Z, et al. Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes. 2016;7(4):323\u20138.","journal-title":"Gut Microbes."},{"key":"809_CR24","doi-asserted-by":"crossref","unstructured":"Feuerstein JD, Nguyen GC, Kupfer SS, Falck-Ytter Y, Singh S; American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease. Gastroenterology. 2017;153(3):827\u201334.","DOI":"10.1053\/j.gastro.2017.07.032"},{"issue":"1","key":"809_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00253-018-9447-x","volume":"103","author":"P Li","year":"2019","unstructured":"Li P, Zhang T, Xiao Y, Tian L, Cui B, Ji G, et al. Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn\u2019s disease. Appl Microbiol Biotechnol. 2019;103(1):349\u201360.","journal-title":"Appl Microbiol Biotechnol."},{"issue":"3","key":"809_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G EuroQol","year":"1990","unstructured":"EuroQol G. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy."},{"issue":"51","key":"809_CR27","doi-asserted-by":"crossref","first-page":"88894","DOI":"10.18632\/oncotarget.21491","volume":"8","author":"T Zhang","year":"2017","unstructured":"Zhang T, Xiang J, Cui B, He Z, Li P, Chen H, et al. Cost-effectiveness analysis of fecal microbiota transplantation for inflammatory bowel disease. Oncotarget. 2017;8(51):88894\u2013903.","journal-title":"Oncotarget."},{"issue":"4","key":"809_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/hec.673","volume":"11","author":"A Tsuchiya","year":"2002","unstructured":"Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11(4):341\u201353.","journal-title":"Health Econ."},{"issue":"5","key":"809_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407\u201315.","journal-title":"N Engl J Med."},{"issue":"9","key":"809_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.7326\/M16-0271","volume":"165","author":"CR Kelly","year":"2016","unstructured":"Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, et al. Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridium difficile infection: a randomized trial. Ann Intern Med. 2016;165(9):609\u201316.","journal-title":"Ann Intern Med."},{"issue":"16","key":"809_CR31","doi-asserted-by":"publisher","first-page":"e6479","DOI":"10.1097\/MD.0000000000006479","volume":"96","author":"A Uygun","year":"2017","unstructured":"Uygun A, Ozturk K, Demirci H, Oger C, Avci IY, Turker T, et al. Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis. Medicine. 2017;96(16):e6479.","journal-title":"Medicine."},{"issue":"11","key":"809_CR32","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/cid\/ciu135","volume":"58","author":"I Youngster","year":"2014","unstructured":"Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58(11):1515\u201322.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"809_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369(3):255\u201363.","journal-title":"N Engl J Med."},{"issue":"12","key":"809_CR34","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","volume":"4","author":"G Gupta","year":"2006","unstructured":"Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4(12):1483\u201390.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"809_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, Hughes PA, Waters O, Bryant RV, Vincent AD, Blatchford P, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156\u201364.","journal-title":"JAMA."},{"issue":"10","key":"809_CR36","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1097\/MIB.0b013e31829ea325","volume":"19","author":"PK Kump","year":"2013","unstructured":"Kump PK, Grochenig HP, Lackner S, Trajanoski S, Reicht G, Hoffmann KM, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis. 2013;19(10):2155\u201365.","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"809_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MIB.0000000000000975","volume":"23","author":"D Ishikawa","year":"2017","unstructured":"Ishikawa D, Sasaki T, Osada T, Kuwahara-Arai K, Haga K, Shibuya T, et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm Bowel Dis. 2017;23(1):116\u201325.","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"809_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00535-016-1271-4","volume":"52","author":"A Nishida","year":"2017","unstructured":"Nishida A, Imaeda H, Ohno M, Inatomi O, Bamba S, Sugimoto M, et al. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol. 2017;52(4):476\u201382.","journal-title":"J Gastroenterol."},{"issue":"2","key":"809_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5217\/ir.2018.16.2.209","volume":"16","author":"NG Fairhurst","year":"2018","unstructured":"Fairhurst NG, Travis SPL. Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis? Intest Res. 2018;16(2):209\u201315.","journal-title":"Intest Res."},{"issue":"1","key":"809_CR40","doi-asserted-by":"publisher","first-page":"e0170922","DOI":"10.1371\/journal.pone.0170922","volume":"12","author":"ND Chu","year":"2017","unstructured":"Chu ND, Smith MB, Perrotta AR, Kassam Z, Alm EJ. Profiling living bacteria informs preparation of fecal microbiota transplantations. PloS One. 2017;12(1):e0170922.","journal-title":"PloS One."},{"issue":"4","key":"809_CR41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajg.2013.59","volume":"108","author":"Z Kassam","year":"2013","unstructured":"Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(4):500\u20138.","journal-title":"Am J Gastroenterol."},{"issue":"10","key":"809_CR42","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","volume":"23","author":"N Narula","year":"2017","unstructured":"Narula N, Kassam Z, Yuan Y, Colombel JF, Ponsioen C, Reinisch W, et al. Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis. Inflamm Bowel Dis. 2017;23(10):1702\u20139.","journal-title":"Inflamm Bowel Dis."},{"issue":"8","key":"809_CR43","doi-asserted-by":"publisher","first-page":"e0161174","DOI":"10.1371\/journal.pone.0161174","volume":"11","author":"S Wang","year":"2016","unstructured":"Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, et al. Systematic review: adverse events of fecal microbiota transplantation. PloS One. 2016;11(8):e0161174.","journal-title":"PloS One."},{"issue":"3","key":"809_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/19490976.2017.1286006","volume":"8","author":"MH Woodworth","year":"2017","unstructured":"Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: a review. Gut Microbes. 2017;8(3):225\u201337.","journal-title":"Gut Microbes."},{"issue":"10","key":"809_CR45","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/ajg.2013.257","volume":"108","author":"S Angelberger","year":"2013","unstructured":"Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013;108(10):1620\u201330.","journal-title":"Am J Gastroenterol."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00809-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-019-00809-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-019-00809-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:10:55Z","timestamp":1659100255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-019-00809-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s40264-019-00809-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"10 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by the publicly donated Intestine Initiative Foundation; Jiangsu Province Creation Team and Leading Talents Project (Zhang F); National Natural Science Foundation of China (81670495, 81600417); Top-Notch Talent Research Projects (LGY2017080); Project of National Health and Family Planning Commission (201502026); and the National Clinical Research Center for Digestive Diseases, Xi\u2019an, China (2015BAI13B07).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Faming Zhang invented the concept of GenFMTer and transendoscopic enteral tubing and related devices. Xiao Ding, Qianqian Li, Pan Li, Ting Zhang, Bota Cui, Guozhong Ji, and Xiang Lu have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was reviewed and approved by the Second Affiliated Hospital of the Nanjing Medical University Institutional Ethical Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}